Clinical Trials · NCT04529278
Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Fondation Hôpital Saint-Joseph
- Enrollment
- 18
- Start date
- Jan 2021
- Locations
- 4 sites, France
- Primary endpoint
- Weight Loss at Week 26